GHD

GHD is one of the largest outpatient health, therapy, and service companies in Germany. Itdelivers medical products, advice and services to more than 665,000 patient suppliers. The company operates in the German healthcare market, characterised by positive long-term demand driven by demographic trends.

Company Background

• Longstanding expertise with +30 years in the German healthcare market.
• Integrated business model that combines the production of medical supplies and compounded pharmaceuticals with wholesale and logistics activities.
• A leading producer of custom-made infusion solutions for cytostatic drugs and parenteral nutrition.
• 31,000 products, 3,000 nursing services and 2,000 residential and nursing homes.
  
  

Vision & Outlook

• Support continued accelerated growth, both organically and through acquisitions.
• Drive further growth in homecare and adjacent healthcare segments, as well as by developing new business areas.

Highlights & Updates

• Launch of new digital guidance service for home-based patients in Germany during the corona pandemic with helpful videos and hygiene tips.
• In 2024, GHD Group sold ForLife Group, which had development and production in Berlin and the homecare distribution ‘Oakmed’ in the UK. This helped GHD streamline its business and strengthen its focus on the homecare sector and its patients.